Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Today, 10th October is the Thames Valley Suicide Prevention Conference in Reading from the Thames Valley Suicide Prevention and Intervention Network (SPIN). Professor Keith Hawton, Director of the Centre for Suicide Research, Department of Psychiatry, University of Oxford, will be chairing the event.

Prof Raanan Gillon, BMA President, Clare Stafford, CEO Charlie Waller Memorial, Prof Keith Hawton and Dr Anne Stewart at the BMA Awards ceremony.

Professor Keith Hawton explains, "The Centre for Suicide Research has been linked with suicide prevention in the Thames Valley for a number of years. Over this time we have seen the introduction and benefits of real time monitoring of deaths by suspected suicide. This involves police liaising with local authorities and coroners, allowing the flow of real time information to be gathered and used, rather than needing to wait for statistics which may or may not appear for another year or two. This gathered information is very valuable. For example, it allows early identification of any clusters of suicides or changes in local patterns. It also means people bereaved by suicide of a family member or friend can be offered support and help at an early stage."

An important aspect of suicide prevention is the fact that it is strongly linked to non-fatal self-harm. Professor Hawton is co-ordinating the Multicentre Study for Self-harm in England. This study gathers data on all self-harm episodes presenting at general hospitals in three centres in England. This information is used for a range of investigations which inform national policy related to self-harm, including hospital management and aftercare of patients who self-harm.

In addition, the Centre for Suicide Research has developed guides on self-harm for both parents and school staff. Young people who self-harm - A Guide for School Staff was published in October 2018. Coping with self-harm - A Guide for Parents and Carers was published in 2016, to date 48,000 hard copies of this guide, for parents and carers, have been distributed by the Charlie Waller Memorial Trust.

Both of these important guides to preventing and coping with self-harm have won British Medical Association High Commendation Awards.

To view the guides:

Young people who self-harm - A Guide for School Staff

Coping with self-harm - A Guide for Parents and Carers

 

New paper - Clustering of suicides in children and adolescents published in The Lancet Child & adolescent Health.

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

How Mindfulness May Improve Body Satisfaction and Mood

New research from Emma Osborne, Research Assistant at the Centre for Research on Eating Disorders (CREDO) at the University of Oxford (and PhD Candidate at the University of Bath), and Dr Melissa Atkinson, University of Bath, investigated two ways in which mindfulness might improve body satisfaction and mood.

Review Highlights Risk Factors Associated with Violence in Schizophrenia

Researchers at Oxford University’s Department of Psychiatry have found that people with schizophrenia and related disorders are at higher-than-average risk of perpetrating violence, but that the overall risk remains low (less than 1 in 20 in women, and less than 1 in 4 for men over a 35-year period for violent arrests and crimes).

New Study will Investigate Brain Fog Symptoms in Post-Hospitalised COVID-19 Patients

C-Fog is a collaborative new study led by Oxford University researcher, Dr Maxime Taquet, which will investigate the reasons why brain fog or cognition problems affect patients after COVID-19 infection. With a better understanding of the mechanisms involved it may be possible to understand how to treat brain fog and help many thousands of people worldwide.

A New Experimental Study Investigated the Effects of Atorvastatin on Emotional Processing

Atorvastatin is one of a group of statins widely used to treat heart and blood vessel diseases. The medication works by lowering cholesterol in the blood. This new study shows that atorvastatin influences the way people experience certain emotions, giving us important insights about disorders such as anxiety and depression.

People with Long-COVID After Hospitalisation Face Limited Recovery After One Year

People who were hospitalised with COVID-19 and continued to experience symptoms five months later, show limited further recovery one year after hospital discharge, according to the latest results of a major national study looking at the long-term health impacts of COVID-19 on hospitalised patients.

The Effects of Social Media on Public Attention and Attitudes Towards COVID-19 Vaccines in the UK

A new study finds that media coverage of positive vaccine research can have a positive effect on overall social media sentiment, countering vaccine misinformation, but the effects wane over time.